Accueil/Actions/THTX

THTX

USD

Theratechnologies Inc. Common Shares

$2.550-0.020 (-0.778%)

Prix en Temps Réel

Healthcare

Biotechnologie

Canada

Graphique des Prix

Loading Chart...

Métriques Clés

Métriques de Marché

Fondamentaux de l'Entreprise

Statistiques de Trading

Métriques de Marché

Ouverture

$2.570

Haut

$2.590

Bas

$2.530

Volume

0.20M

Fondamentaux de l'Entreprise

Capitalisation Boursière

118.1M

Industrie

Biotechnologie

Pays

Canada

Statistiques de Trading

Volume Moyen

3.01M

Bourse

NCM

Devise

USD

Intervalle sur 52 Semaines

Bas $1.12Actuel $2.550Haut $3.13

Actualités Connexes

2 mai 2025 · 11:30

GlobeNewswire

Theratechnologies Presents Novel Data at ACTHIV 2025 Underscoring Importance of Managing Excess Visceral Abdominal Fat (EVAF) in People with HIV

VAMOS analysis highlights link between EVAF and reduced muscle quality Case series reports success with combination tesamorelin/GLP-1 receptor agonist therapy MONTREAL, May 02, 2025 (GLOBE NEWSWIRE) --

Theratechnologies Presents Novel Data at ACTHIV 2025 Underscoring Importance of Managing Excess Visceral Abdominal Fat (EVAF) in People with HIV

15 avr. 2025 · 22:00

GlobeNewswire

Theratechnologies Provides Update on Sale Process

MONTREAL, April 15, 2025 (GLOBE NEWSWIRE) -- Theratechnologies Inc. ("Theratechnologies" or the "Company") (TSX:TH) (NASDAQ:THTX), a commercial-stage biopharmaceutical company, today announced that following careful

Theratechnologies Provides Update on Sale Process

12 avr. 2025 · 12:46

BusinessWire

Soleus Capital Issues Letter to The Board of Theratechnologies

Soleus Capital Management, L.P. ("Soleus Capital"), a healthcare investment firm which owns in excess of 10% of the stock of Theratechnologies Inc. (NASDAQ:THTX) (the "Company"), today sent a letter to the Board of

Soleus Capital Issues Letter to The Board of Theratechnologies

11 avr. 2025 · 21:00

GlobeNewswire

Theratechnologies Responds to Future Pak's Press Release and Announces Exclusive Discussions with Another Potential Acquiror for the Sale of the Company

MONTREAL, April 11, 2025 (GLOBE NEWSWIRE) -- Theratechnologies Inc. ("Theratechnologies" or the "Company") (TSX:TH) (NASDAQ:THTX), a commercial-stage biopharmaceutical company, wishes to address its shareholders in

Theratechnologies Responds to Future Pak's Press Release and Announces Exclusive Discussions with Another Potential Acquiror for the Sale of the Company

11 avr. 2025 · 13:57

BusinessWire

Future Pak Submits Proposals to Acquire Theratechnologies Inc., Offering up to $255 Million in Total Value

Future Pak, LLC ("Future Pak") today announced that it has submitted two formal proposals since January to acquire all outstanding shares of common stock of Theratechnologies Inc. ("Theratechnologies") (NASDAQ:THTX).